ARCHIVES

Switching to Tasigna After Gleevec Therapy Can Achieve Deeper Molecular Response

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

FCRF Contracts Recompetition Will Be Along Same Lines As in 1982 But for at Least Seven Years

July 5, 1985

Pitt Criticizes NCI Stance On Repayment For Fraud Trials

September 9, 1994

In Brief: CDP Services Wins ASC Planning Contract; Jury Finds Sarin Guilty of Embezzlement

July 17, 1992

NIOSH To Fund 21 Projects With NCI Money

February 25, 1977

NCI Budget 6% Below 1980 Level; Prevention, Groups, Lost Most

February 8, 1991

In Brief: Antman, Chabner Vie For ASCO President-Elect; Irwin Krakoff Is 1993 Karnofsky Lecturer

January 8, 1993